Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Pediatric MDS
NCT00098683Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of amifostine in myelodysplastic syndrome (MDS), sponsored by Children's Oncology Group. Started Jan 2005; status: completed.
02
Drugs
amifostine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00098683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098683.